Truist Financial
PFE icon

Truist Financial’s Pfizer PFE Stock Holding History

Truist Financial’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-10,000
Closed -$392K – 2794
2021
Q2 		$392K Buy
+10,000
New +$389K ﹤0.01% 2219
2020
Q2 		– Sell
-23,820
Closed -$738K – 2546
2020
Q1 		$738K Buy
+23,820
New +$812K ﹤0.01% 1382

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Truist Financial's PFE Position: Q1 2026 in Review

Truist Financial increased its Pfizer (PFE) stake by 2.8% in Q1 2026, buying an estimated $1.78M and bringing the position to 2,470,900 shares worth $69.4M. The position accounts for 0.09% of the portfolio, ranked #189.

Truist Financial first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $283M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Truist Financial held 2,470,900 shares of Pfizer worth $69.4M as of Q1 2026.
  • Truist Financial bought 67,026 Pfizer shares in Q1 2026, an estimated $1.78M.
  • Pfizer made up 0.09% of Truist Financial's portfolio in Q1 2026, its #189 holding.
  • Truist Financial first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Truist Financial's Pfizer position peaked at $283M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.